Machine learning model for early diagnosis of breast cancer based on PiRNA expression with CA153.

Journal: Scientific reports
Published Date:

Abstract

PIWI-interacting RNAs (piRNAs) have been implicated in the biological processes of various cancers. This study aimed to investigate the diagnostic potential of circulating piRNAs in breast cancer (BC) using machine learning (ML) frameworks. A serum tri-piRNA signature (piR-139966, piR-2572505, piR-2570061) was selected via piRNA sequencing, validated by qPCR, and then analyzed in combination with related clinical factors. Predictive ML models for early diagnosis of BC combining piRNA expression with CA153 were constructed using 10 ML algorithms and evaluated by 8 performance metrics. Serum levels of piR-139966, piR-2572505, and piR-2570061 were significantly upregulated in early-stage BC patients compared to matched healthy controls. This tri-piRNA panel demonstrated enhanced diagnostic precision for BC detection and exhibited complementary value to CA153 measurements, whether used alone or combined. Through systematic ML optimization, we developed a stratified diagnostic model where XGBoost algorithm showed optimal performance in both training and validation cohorts for early-stage BC identification. With XGBoost algorithms applied to piRNA expression along with CA153, we developed and validated a predictive ML model with superior diagnostic accuracy compared to conventional approaches.

Authors

  • Limin Niu
    Department of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jiyan Road 440#, Jinan, 250117, Shandong, PR China.
  • Weicheng Zhou
    Core & Molecular Lab (CML), Roche Diagnostics (Shanghai) Limited, Shanghai, PR China.
  • Xiao Li
    Department of Inner Mongolia Clinical Medicine College, Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Jinming Zhao
    Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Nanning, Guangxi Zhuang Autonomous Region, China.
  • Lei Li
    Department of Thoracic Surgery, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China.
  • Xingguo Song
    Department of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jiyan Road 440#, Jinan, 250117, Shandong, PR China. xgsong@sdfmu.edu.cn.